English | Español

Regulatory
+ Regulatory
Carol Ostrow | Nov 17, 2017

American Diabetes Association attains five-year plan with CDC for multistate outreach
+ Regulatory
John Breslin | Nov 17, 2017

Rising number of doctors employed by hospitals leading to higher Medicare costs, study shows
+ Regulatory
Marian Johns | Nov 17, 2017

Novartis submits application to EMA for one-time cancer treatment
+ Regulatory
John Breslin | Nov 17, 2017

Advocates praise Gates' $100 million investment in Alzheimer's research
+ Technology/Innovation
Carol Ostrow | Nov 17, 2017

Diabetes 360 survey shows patient desire for more holistic care
+ Community
Carol Ostrow | Nov 16, 2017

STORM Therapeutics names Institute of Cancer Research CEO to board
+ Technology/Innovation
Carol Ostrow | Nov 16, 2017

European study demonstrates economic benefits of Tresiba
+ Regulatory
Marian Johns | Nov 16, 2017

Patient groups say Orphan Drug Tax Credit repeal could result in fewer treatments for rare diseases

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'